Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,302.40
(
0.70%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.55
(
-0.10%
)
Bitcoin
74,205.92
(
0.36%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ThomasS post# 65061

Tuesday, 08/05/2008 7:46:23 AM

Tuesday, August 05, 2008 7:46:23 AM

Post# of 257253
VRUS – Data from the 500mg BID and 1500mg BID cohorts of this study were reported in April (#msg-28837612). What’s new in today’s PR are preliminary data from the 1000mg BID cohort. Data from a fourth cohort (1500mg BID in treatment-refractory gentotype-2/3) have not yet been reported.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today